INHIBITION OF HUMAN CYP3A CATALYZED 1'-HYDROXY MIDAZOLAM FORMATION BY KETOCONAZOLE, NIFEDIPINE, ERYTHROMYCIN, CIMETIDINE, AND NIZATIDINE

被引：145

作者：

WRIGHTON, SA

RING, BJ

机构：

[1] Dept. of Drug Metabolism Disposition, Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285

来源：

PHARMACEUTICAL RESEARCH | 1994年 / 11卷 / 06期

关键词：

CYTOCHROME P450; INHIBITION; ENZYME KINETICS; MIDAZOLAM; KETOCONAZOLE; NIFEDIPINE; ERYTHROMYCIN; CIMETIDINE; NIZATIDINE;

D O I：

10.1023/A:1018906614320

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

[No abstract available]

引用

页码：921 / 924

页数：4

共 14 条

[1] INVITRO FORECASTING OF DRUGS WHICH MAY INTERFERE WITH THE BIOTRANSFORMATION OF MIDAZOLAM
GASCON, MP
DAYER, P
[J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1991, 41 (06) : 573 - 578
[2] CHANGES IN THE PHARMACOKINETICS AND ELECTROCARDIOGRAPHIC PHARMACODYNAMICS OF TERFENADINE WITH CONCOMITANT ADMINISTRATION OF ERYTHROMYCIN
HONIG, PK
WOOSLEY, RL
ZAMANI, K
CONNER, DP
CANTILENA, LR
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1992, 52 (03) : 231 - 238
[3] TERFENADINE-KETOCONAZOLE INTERACTION - PHARMACOKINETIC AND ELECTROCARDIOGRAPHIC CONSEQUENCES
HONIG, PK
WORTHAM, DC
ZAMANI, K
CONNER, DP
MULLIN, JC
CANTILENA, LR
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12): : 1513 - 1518
[4] NIFEDIPINE - RELATIONSHIP BETWEEN PHARMACOKINETICS AND PHARMACODYNAMICS
KLEINBLOESEM, CH
VANBRUMMELEN, P
BREIMER, DD
[J]. CLINICAL PHARMACOKINETICS, 1987, 12 (01) : 12 - 29
[5] KRONBACH T, 1989, MOL PHARMACOL, V36, P89
[6] MECHANISMS OF THE INHIBITION OF CYTOCHROME-P-450-MEDIATED DRUG OXIDATION BY THERAPEUTIC AGENTS
MURRAY, M
[J]. DRUG METABOLISM REVIEWS, 1987, 18 (01) : 55 - 81
[7] THE P450 SUPERFAMILY - UPDATE ON NEW SEQUENCES, GENE-MAPPING, ACCESSION NUMBERS, EARLY TRIVIAL NAMES OF ENZYMES, AND NOMENCLATURE
NELSON, DR
KAMATAKI, T
WAXMAN, DJ
GUENGERICH, FP
ESTABROOK, RW
FEYEREISEN, R
GONZALEZ, FJ
COON, MJ
GUNSALUS, IC
GOTOH, O
OKUDA, K
NEBERT, DW
[J]. DNA AND CELL BIOLOGY, 1993, 12 (01) : 1 - 51
[8] UNDERSTANDING CONSEQUENCES OF CONCURRENT THERAPIES
PECK, CC
TEMPLE, R
COLLINS, JM
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 269 (12): : 1550 - 1552
[9] Segel IH, 1975, ENZYME KINETICS
[10] CLINICAL RELEVANCE OF CIMETIDINE DRUG-INTERACTIONS
SHINN, AF
[J]. DRUG SAFETY, 1992, 7 (04) : 245 - 267

← 1 2 →